Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label ExtensionRenato Mantegazza, Maria da Penha Ananias Morita, Heather Booth et al.|Neurology|2020Cited by 80
Eculizumab improves fatigue in refractory generalized myasthenia gravisHenning Andersen, Érica Nogueira Coelho, Renato Mantegazza et al.|Quality of Life Research|2019Cited by 58
Clinical and molecular spectrum of TK2-deficiency: a large Brazilian cohortCristiane Araújo Martins Moreno, Edmar Zanoteli, Mariana Cunha Artilheiro et al.|Scientific Reports|2025Cited by 4